These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


281 related items for PubMed ID: 8947040

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.
    Guo Z, Yikang S, Yoshida H, Mak TW, Zacksenhaus E.
    Cancer Res; 2001 Dec 01; 61(23):8395-400. PubMed ID: 11731416
    [Abstract] [Full Text] [Related]

  • 3. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y, Zacksenhaus E.
    Oncogene; 2000 Dec 07; 19(52):6065-73. PubMed ID: 11146559
    [Abstract] [Full Text] [Related]

  • 4. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
    Divan A, Lawry J, Dunsmore IR, Parsons MA, Royds JA.
    Cancer Res; 2001 Apr 01; 61(7):3157-63. PubMed ID: 11306502
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cell-autonomous and non-cell-autonomous functions of the Rb tumor suppressor in developing central nervous system.
    Lipinski MM, Macleod KF, Williams BO, Mullaney TL, Crowley D, Jacks T.
    EMBO J; 2001 Jul 02; 20(13):3402-13. PubMed ID: 11432828
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress.
    Yin Y, Solomon G, Deng C, Barrett JC.
    Mol Carcinog; 1999 Jan 02; 24(1):15-24. PubMed ID: 10029406
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW, Sørensen TS, Shikama N, La Thangue NB.
    Oncogene; 1998 May 28; 16(21):2695-710. PubMed ID: 9652736
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ.
    Clin Cancer Res; 2000 Mar 28; 6(3):1190-7. PubMed ID: 10741751
    [Abstract] [Full Text] [Related]

  • 18. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H, Iavarone A, Reeves SA.
    Oncogene; 1998 Mar 26; 16(12):1513-23. PubMed ID: 9569018
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential post-translational modification of the tumour suppressor proteins Rb and p53 modulate the rates of radiation-induced apoptosis in vivo.
    Wallace M, Coates PJ, Wright EG, Ball KL.
    Oncogene; 2001 Jun 21; 20(28):3597-608. PubMed ID: 11439323
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.